The B16-3340 tumor-bearing mice displayed enhanced CD8+ T-cell function, marked by a substantial increase in IFN-γ+ CD8+ and IL17+ CD8+ T cells, indicating robust activation of both  Tc1 and Tc17 effector programs (Fig. 3A, 3B). This evidence concerns the gene IL17A and neoplasm.